FDA Anticipated to Issue EUA for Pfizer COVID-19 Vaccine
The U.S. Food and Drug Administration (FDA) is widely anticipated to issue its first emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine at any point in the coming days. Yesterday, during a day-long meeting, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) deliberated the safety and efficacy of the vaccine candidate, ultimately…
Read More »